The Application Notebook
Increased temperature has been used to assist the elimination of organic modifier required in the mobile phase, to achieve analyte separation in pure aqueous mobile phases.
Increased temperature has been used to assist the elimination of organic modifier required in the mobile phase, to achieve analyte separation in pure aqueous mobile phases.
Generally, LC separations are run at temperatures between 25 and 40 °C. At higher temperatures, solvent viscosity is lower, which allows the use of higher flow rates to increase speed, without losing efficiency. Reduced mobile phase viscosity results in an increase in analyte diffusivity, which improves mass transfer, consequently the chromatographic peaks obtained are sharper, improving the sensitivity of the analysis.
Temperature can also be used to modify the elution strength of the mobile phase. If the temperature of water is increased its elution strength also increases due to a decreased dielectric constant. At 190 °C, the dielectric constant of water is similar to that of acetonitrile at 20 °C, indicating that the use of 100% water mobile phase can potentially be used as an eluent in analytical HPLC.
Although these positive temperature effects on HPLC separations have been understood for many years, the use of ultra-high temperatures has not been fully exploited. One significant reason for this is the poor temperature stability of silica based stationary phases. Hypercarb (Porous Graphitic Carbon) columns have no bonded phase and can withstand temperatures in excess of 200 °C. This article describes the retention of a mixture of purines and pyrimidines at high temperatures on a Hyercarb column using a 100% aqueous mobile phase.
The retention and separation of a mixture of purines and pyrimidines, obtained with a mobile phase of water, acetonitrile, and formic acid, at 50 °C is shown in Figure 1a. By removing the organic component (acetonitrile) and the electronic modifier (formic acid) from the mobile phase, elution strength is greatly reduced, and at conventional temperatures the mobile phase is too weak to elute the solutes from the PGC column.
Figure 1: 1) Cytosine, 2) Uracil, 3) Thymine, 4 Hypoxanthine, 5) Guanine, 6) Xanthine
In Figure 1b, the purines and pyrimidines are separated with a mobile phase of pure water at 190 °C. The same elution order is maintained, although there is a slight change in the separation selectivity obtained with 100 % water at 190 °C. The lower solvent viscosity allows a higher flow rate to be used, reducing analysis time and improving mass transfer. The overall peak symmetry is improved at this high temperature with asymmetry values for peaks 3 and 4 (measured at 10 % height) being reduced from 1.37 and 1.56 under conventional conditions to 1.22 and 1.19 respectively at 190 °C.
The use of ultra-high temperature can be used to eliminate the requirement for organic solvents in a HPLC mobile phase. The separation of purines and pyrimidines is achieved in less time and with improved peak shape.
Thermo Fisher Scientific
112 Chadwick Road, Runcorn WA7 1PR, UK
tel. +44 (0) 1928 588089, fax: +44 (0) 1928 581078
Website: www.thermo.com
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.